FDA Approved: SUMATRIPTAN — Supplemental Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)

View source ↗

Summary

FDA approved a supplemental application for Sumatriptan from Sun Pharmaceutical Industries, Inc., for the marketed product used to treat acute migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Sumatriptan (Sumatriptan)

Snippet

SUPPL AP for SUMATRIPTAN (SUMATRIPTAN)